glp 1 agonist with dpp 4 inhibitor Clinical Use of DPP-4 Inhibitors DPP-4 inhibitors and GLP-1RAs: cardiovascular
Description
Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China

By activating GLP-1 receptors in multiple areas particularly the hypothalamus and vagus nerve this therapy helps reduce appetite, improve glycaemic control, and support healthier eating behaviours

Offers accountability and motivation

VLDL, very low density lipoprotein
69705-5/asset/079012c9-a24f-4391-ba39-2f5d03668f6f/main.assets/gr1_lrg.jpg)
[cited 2025 Feb 1]
